A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease

By Dessureault Sophie   Noyes David   Lee David   Dunn Mary   Janssen William   Cantor Alan   Sotomayor Eduardo   Messina Jane   Antonia Scott  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 869-884

Springer Publishing Company

Access to resources Recommend Favorite

Expression of the co-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer in vitro

By              

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 262-268

Spandidos Publications

Access to resources Recommend Favorite

The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer

By Zhang Zhen   Xu Xiaoling   Zhang Xiaoren   Chen Xiqian   Chen Qingge   Dong Lina   Hu Zhiming   Li Jinlong   Gao Jimin  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1111-1118

Informa Healthcare

Access to resources Recommend Favorite

MHC class II and CD80 tumor cell–based vaccines are potent activators of type 1 CD4⁺ T lymphocytes provided they do not coexpress invariant chain

By Ilkovitch Dan   Ostrand-Rosenberg Suzanne  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 525-532

Springer Publishing Company

Access to resources Recommend Favorite

Selfcomplementary adenoassociated virus 5mediated gene transduction of a novel CD40L mutant confers direct antitumor effects in lung carcinoma

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 482-488

Spandidos Publications

Access to resources Recommend Favorite